載入...
TARGETING LEUKEMIA STEM CELL RESISTANCE IN CHRONIC MYELOGENOUS LEUKEMIA
A major limitation of current leukemia treatment is that most patients ultimately relapse. Leukemia cells show heterogeneous potential and response to treatment. We have shown that primitive leukemia stem cells (LSC) in chronic myelogenous leukemia resist elimination by treatment, and persist as a s...
Na minha lista:
| 發表在: | Trans Am Clin Climatol Assoc |
|---|---|
| 主要作者: | |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Clinical and Climatological Association
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6736008/ https://ncbi.nlm.nih.gov/pubmed/31516189 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|